文献速递产科母胎医学

低风险游离DNA产前筛查后游离DNA筛查性能、产前操作选择及孕期发现的染色体异常

Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening.
PubMed 文献 · Prenat Diagn · 2023-01-21

单中心研究连续检测38289份样本的游离DNA筛查,检出720例(1.9%)为非整倍体高风险;高风险单胎妊娠中T21、T18、T13的阳性预测值分别为98.5%、92.5%、55.2%,性染色体非整倍体为30.6%~95.2%。筛查阴性妊娠的细胞遗传学检测发现64例(12.7%)cfDNA未检出的染色体异常,另有15例(0.04%)常见非整倍体假阴性。

要点

  • 高风险单胎妊娠中T21阳性预测值98.5%,T18为92.5%,T13为55.2%。
  • 性染色体非整倍体阳性预测值范围为30.6%~95.2%。
  • 筛查阴性妊娠中细胞遗传学检出64例(12.7%)染色体异常,含三倍体30例。

核心结论

  • 在该一般风险产科人群中,cfDNA筛查对胎儿非整倍体的检测高度准确。
  • 胎儿超声和产前诊断检测对于识别筛查为低风险的妊娠中的染色体异常具有重要作用。

研究设计与样本

  • 单中心产前cfDNA筛查检测研究,检测21、18、13三体(T21、T18、T13)及性染色体非整倍体(SCAs)。
  • 连续检测38289份样本。
  • 回顾筛查阴性妊娠的检测性能、产前操作选择及细胞遗传学结果。

主要发现

  • 38289份连续样本中检出720例(1.9%)为非整倍体高风险。
  • 高风险单胎妊娠阳性预测值:T21为98.5%,T18为92.5%,T13为55.2%;SCAs为30.6%~95.2%。
  • 多数女性对T21、T18、T13的产前诊断选择绒毛膜绒毛取样;SCAs常选择羊膜腔穿刺和(或)产后检测。
  • 616例筛查阴性妊娠的细胞遗传学检测发现64例(12.7%)cfDNA未检出的染色体异常,包括三倍体(n=30)及致病性和可能致病性拷贝数变异(n=34)。
  • 另发现15例(0.04%)常见非整倍体假阴性结果。

临床怎么用

  • 作者认为,胎儿超声和产前诊断检测对于识别筛查为低风险的妊娠中的染色体异常具有重要作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the performance of cell-free DNA (cfDNA) screening for common fetal aneuploidies, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cfDNA screening. METHOD: A single-center prenatal cfDNA screening test was employed to detect trisomies 21, 18, and 13 (T21, T18, T13) and sex chromosome aneuploidies (SCAs). Test performance, choice of prenatal procedure, and cytogenetic results in pregnancies with low-risk cfDNA screening were reviewed. RESULTS: CfDNA screening of 38,289 consecutive samples identified 720 (1.9%) pregnancies at increased risk for aneuploidy. Positive predictive values (PPVs) for high-risk singleton pregnancies were 98.5% (T21), 92.5% (T18) and 55.2% (T13). PPVs for SCAs ranged from 30.6% to 95.2%. Most women elected chorionic villus sampling for prenatal diagnosis of T21, T18 and T13; amniocentesis and/or postnatal testing were commonly chosen for SCAs. Cytogenetic tests from 616 screen-negative pregnancies identified 64 cases (12.7%) with chromosome conditions not detected by cfDNA screening, including triploidy (n = 30) and pathogenic and likely pathogenic copy number variants (n = 34). A further 15 (0.04%) false-negative common aneuploidy results were identified. CONCLUSIONS: CfDNA screening was highly accurate for detecting fetal aneuploidy in this general-risk obstetric population. Fetal ultrasound and prenatal diagnostic testing were important in identifying chromosome conditions in pregnancies screened as low-risk.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Scarff KL, Flowers N, Love CJ, et al. Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening. Prenat Diagn. 2023. PMID: 36617980. doi:10.1002/pd.6307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。